HealthEquity Past Earnings Performance
Past criteria checks 2/6
HealthEquity's earnings have been declining at an average annual rate of -43.2%, while the Healthcare industry saw earnings growing at 4.6% annually. Revenues have been growing at an average rate of 18.5% per year. HealthEquity's return on equity is 2.7%, and it has net margins of 5.6%.
Key information
-43.2%
Earnings growth rate
-49.5%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 18.5% |
| Return on equity | 2.7% |
| Net Margin | 5.6% |
| Last Earnings Update | 31 Jan 2024 |
Recent past performance updates
Recent updates
Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?
May 03
Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues
Apr 11HealthEquity: Multiple Compression Has Finally Made It A Buy
Mar 21Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects
Dec 28Is HealthEquity (NASDAQ:HQY) A Risky Investment?
Nov 17HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price
Oct 26Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Jul 27HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jul 07Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Apr 18Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Mar 14Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Dec 24Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Dec 02Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 11These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
Sep 08HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M
Sep 06HealthEquity: Asymmetry In Valuation Continues To Widen
Aug 25HealthEquity COO steps down, CEO to assume his responsibilities
Aug 02Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Jul 27Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Jul 06These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
May 24Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Apr 12An Intrinsic Calculation For HealthEquity, Inc. (NASDAQ:HQY) Suggests It's 29% Undervalued
Mar 16HealthEquity: Quality Firm, But Not Likely Worth The Price
Mar 01These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
Jan 28Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Jan 02HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 26% Below Their Intrinsic Value Estimate
Dec 09Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Oct 10Is There An Opportunity With HealthEquity, Inc.'s (NASDAQ:HQY) 36% Undervaluation?
Sep 05Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Aug 09Revenue & Expenses BreakdownBeta
How HealthEquity makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jan 24 | 1,000 | 56 | 183 | 219 |
| 31 Oct 23 | 971 | 29 | 177 | 216 |
| 31 Jul 23 | 938 | 13 | 173 | 210 |
| 30 Apr 23 | 901 | -8 | 169 | 201 |
| 31 Jan 23 | 862 | -26 | 166 | 193 |
| 31 Oct 22 | 831 | -59 | 162 | 187 |
| 31 Jul 22 | 795 | -62 | 152 | 176 |
| 30 Apr 22 | 778 | -55 | 148 | 167 |
| 31 Jan 22 | 757 | -44 | 144 | 157 |
| 31 Oct 21 | 741 | -6 | 142 | 144 |
| 31 Jul 21 | 741 | 1 | 144 | 136 |
| 30 Apr 21 | 728 | 4 | 139 | 129 |
| 31 Jan 21 | 734 | 9 | 134 | 125 |
| 31 Oct 20 | 747 | 3 | 122 | 124 |
| 31 Jul 20 | 724 | -20 | 132 | 117 |
| 30 Apr 20 | 635 | 0 | 117 | 98 |
| 31 Jan 20 | 532 | 40 | 105 | 78 |
| 31 Oct 19 | 407 | 53 | 97 | 56 |
| 31 Jul 19 | 320 | 90 | 68 | 41 |
| 30 Apr 19 | 304 | 93 | 66 | 38 |
| 31 Jan 19 | 287 | 74 | 63 | 35 |
| 31 Oct 18 | 272 | 67 | 60 | 33 |
| 31 Jul 18 | 258 | 61 | 56 | 31 |
| 30 Apr 18 | 244 | 56 | 52 | 29 |
| 31 Jan 18 | 230 | 47 | 48 | 27 |
| 31 Oct 17 | 216 | 46 | 44 | 26 |
| 31 Jul 17 | 202 | 41 | 42 | 26 |
| 30 Apr 17 | 190 | 32 | 40 | 24 |
| 31 Jan 17 | 178 | 26 | 38 | 22 |
| 31 Oct 16 | 167 | 25 | 36 | 21 |
| 31 Jul 16 | 155 | 24 | 33 | 19 |
| 30 Apr 16 | 141 | 20 | 30 | 18 |
| 31 Jan 16 | 127 | 17 | 27 | 17 |
| 31 Oct 15 | 116 | 15 | 26 | 15 |
| 31 Jul 15 | 107 | 14 | 24 | 14 |
| 30 Apr 15 | 97 | 13 | 22 | 12 |
| 31 Jan 15 | 88 | 12 | 19 | 11 |
| 31 Oct 14 | 80 | 1 | 16 | 9 |
| 31 Jul 14 | 74 | -1 | 15 | 8 |
| 30 Apr 14 | 68 | -4 | 13 | 8 |
| 31 Jan 14 | 62 | -7 | 12 | 7 |
Quality Earnings: HQY has high quality earnings.
Growing Profit Margin: HQY became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HQY's earnings have declined by 43.2% per year over the past 5 years.
Accelerating Growth: HQY has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: HQY has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (12.5%).
Return on Equity
High ROE: HQY's Return on Equity (2.7%) is considered low.